FDA Approved: TRI-MILI — Supplemental Application (Aurobindo Pharma Limited)

View source ↗

Summary

FDA approved a supplemental application for TRI-MILI (norgestimate and ethinyl estradiol) from Aurobindo Pharma Limited, updating the product labeling.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Contraception

Drugs mentioned

• TRI-MILI (Norgestimate and Ethinyl Estradiol)

Snippet

SUPPL AP for TRI-MILI (NORGESTIMATE AND ETHINYL ESTRADIOL)